Tesofensine Therapy: Complete Guide
Tesofensine is a triple monoamine reuptake inhibitor — it blocks reuptake of dopamine, noradrenaline and serotonin — originally developed for Parkinson's and Alzheimer's disease, where it failed, and later repurposed for obesity after weight loss was noticed as a side effect. It is not a peptide, despite frequently appearing on peptide vendor sites. It has completed phase 3 obesity trials and is not FDA-approved.
Fact-checking at PeptideProbe is editorial, not clinical. Our editors check claims, dosing figures, and trial results against primary sources; they are not licensed clinicians and do not provide medical review. Nothing here is medical advice — talk to a qualified healthcare provider before starting any therapy.
What is Tesofensine?
Tesofensine is a triple monoamine reuptake inhibitor — it blocks reuptake of dopamine, noradrenaline and serotonin — originally developed for Parkinson's and Alzheimer's disease, where it failed, and later repurposed for obesity after weight loss was noticed as a side effect. It is not a peptide, despite frequently appearing on peptide vendor sites. It has completed phase 3 obesity trials and is not FDA-approved.
How Tesofensine Works
Tesofensine works through specific biological pathways to produce its therapeutic effects. Consult with a qualified provider for detailed information about how this peptide therapy works for your specific condition.
Benefits & Uses
Produced greater weight loss than placebo in phase 2 obesity trials. Because it acts on central monoamine systems rather than incretin pathways, it is mechanistically unrelated to the GLP-1 drugs.
Clinical Evidence & Research
Clinical research on Tesofensine continues to evolve. Tesofensine has been studied in preclinical and clinical settings. Speak with your provider about the current evidence base.
Side Effects & Safety
Dry mouth, insomnia, nausea, and constipation. Of particular note, monoamine reuptake inhibition can raise heart rate and blood pressure, and mood changes have been reported. This is a stimulant-like mechanism, not a metabolic one, and its cardiovascular safety has not been established to FDA standards.
Dosing & Administration
Dosing protocols for Tesofensine should be determined by a qualified healthcare provider based on your individual health profile, treatment goals, and response to therapy. Self-dosing without medical supervision is not recommended.
Find Tesofensine Providers Near You
Search our directory for qualified providers offering Tesofensine therapy. Filter by location, telehealth, and more.
Browse ProvidersTesofensine FAQ
Produced greater weight loss than placebo in phase 2 obesity trials. Because it acts on central monoamine systems rather than incretin pathways, it is mechanistically unrelated to the GLP-1 drugs.
Costs vary by provider and location. Contact providers directly for current pricing.
Tesofensine has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Dry mouth, insomnia, nausea, and constipation. Of particular note, monoamine reuptake inhibition can raise heart rate and blood pressure, and mood changes have been reported. This is a stimulant-like mechanism, not a metabolic one, and its cardiovascular safety has not been established to FDA standards.
PeptideProbe lists 0 providers offering Tesofensine therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
What Tesofensine is used for
Each of these reviews the evidence for that goal, including where it is weaker than the marketing suggests.
Stay Updated
Get notified when new peptide therapy providers join in your area.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.